Klotho has been widely shown to suppress P38 mitogen-activated protein kinase (MAPK) activation in various pathological conditions, including neurodegenerative diseases [67–70], thereby reducing the consequences of its activation, such as brain edema, BBB disruption, neuroinflammation, and programmed cell death [71]. The gene discussed is KL; the disease is neurodegenerative disease.